Kulthanan, Kanokvalai <br/><br/>
Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.  [electronic resource] 

 -  The Journal of dermatological treatment  Mar 2017 
 - 160-165 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-1753 
<br/><br/><label>Standard No.: </label>10.1080/09546634.2016.1200710  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Allergic Agents--administration & dosage<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Chronic Disease<br/>Cyclosporine--therapeutic use<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Histamine H1 Antagonists--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Omalizumab--administration & dosage<br/>Prednisolone--therapeutic use<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Urticaria--drug therapy